Skin Manifestation of SARS-CoV-2: The Italian Experience
At the end of December 2019, a new coronavirus denominated Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was identified in Wuhan, Hubei province, China. Less than three months later, the World Health Organization (WHO) declared coronavirus disease-19 (COVID-19) to be a global pandemic...
Main Authors: | Gerardo Cazzato, Caterina Foti, Anna Colagrande, Antonietta Cimmino, Sara Scarcella, Gerolamo Cicco, Sara Sablone, Francesca Arezzo, Paolo Romita, Teresa Lettini, Leonardo Resta, Giuseppe Ingravallo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/8/1566 |
Similar Items
-
Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives
by: Gerardo Cazzato, et al.
Published: (2021-07-01) -
“Animal-Type Melanoma/Pigmented Epithelioid Melanocytoma”: History and Features of a Controversial Entity
by: Gerardo Cazzato, et al.
Published: (2021-07-01) -
HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study
by: Gerardo Cazzato, et al.
Published: (2021-08-01) -
The Multiple Faces of Nodular Trichoblastoma: Review of the Literature with Case Presentation
by: Gerardo Cazzato, et al.
Published: (2021-07-01) -
GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives
by: Gerardo Cazzato, et al.
Published: (2021-11-01)